Register for the Nexstim nTMS Product Webinar: Therapy with NBS 6
If you would like to join our special issue product webinar and simulated demonstration on the use of nTMS therapy with NBS 6 on May 4 at 11am Eastern Time / 4 pm GMT, please sign up below. If this time is not convenient for you, don't hesitate to contact us to set up a remote live demonstration at a time that suits you better: info@nexstim.com
Indications for use:
NBS 6 (FDA K170902, K182700): Nexstim NBS 6 is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. The Nexstim NBS 6 is intended to be used by trained clinical professionals.
